<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82303">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01912248</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2012-143</org_study_id>
    <nct_id>NCT01912248</nct_id>
  </id_info>
  <brief_title>Acute Effect of Strength Training on Blood Pressure in Cardiac Patients</brief_title>
  <official_title>Acute Effect of Strength Training on Blood Pressure in Cardiac Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christian Dall</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <authority>Denmark:National institute of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Moderate and heavy strength training exercise and the acute blood pressure rise in cardiac
      patient, how high?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      12 heart transplant recipients 12 heart failure patients 12 patients with ischemic heart
      disease
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>systolic blood pressure</measure>
    <time_frame>one test, 1 hour, continuated systolic blood pressure surveliance</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>diastolic blood pressure</measure>
    <time_frame>one test 1 hour, continuated bloodpressure surveliance</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Heart Failure</condition>
  <condition>Ischemic Heart Disease</condition>
  <condition>Heart Transplant Recipients</condition>
  <arm_group>
    <arm_group_label>Heart failure</arm_group_label>
    <description>strength training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Transplant recipients</arm_group_label>
    <description>strength training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with ischemic heart disease</arm_group_label>
    <description>strength training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>strength training</intervention_name>
    <description>strength training, lower limb.</description>
    <arm_group_label>Heart failure</arm_group_label>
    <arm_group_label>Heart Transplant recipients</arm_group_label>
    <arm_group_label>patients with ischemic heart disease</arm_group_label>
    <other_name>one hour of strength training.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        12 heart transplant recipients 12 heart failure patients 12 patients with ischemic disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years

          -  no strength training &gt; 3 month

          -  speak and understand danish

        Exclusion Criteria:

          -  cancer

          -  serum creatinin above 200 mmol/l

          -  re-transplantation

          -  Ejection fraction &gt; 35
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian H Dall, cand.scient</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christian Dall</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian H Dall, Cand.scient</last_name>
      <phone>00 45 28604402</phone>
      <email>christianhavedall@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>H</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 23, 2013</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Christian Dall</investigator_full_name>
    <investigator_title>cand.scient</investigator_title>
  </responsible_party>
  <keyword>acute rise of systolic and diastolic bloodpressure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
